Hanna Kim Gaggin, MD, MPH, FACC

Hanna Gaggin

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Roche Diagnostics(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT) OFFICER, DIRECTOR ETC: MGH Cardiology Board Review Book(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Roche Diagnostics(SIGNIFICANT), Jana Care(SIGNIFICANT), Ortho Clinical(SIGNIFICANT), Novartis Corporation(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Radiometer(SIGNIFICANT)

View Full Disclosure